Work

P37 Phase 1 evaluation of bintrafusp alfa (M7824), a bifunctional fusion protein targeting TGF-β and PD-L1, in cervical cancer

Year: 2019

Type: conference-abstract

Source: International Journal of Gynecological Cancer

DOI: 10.1136/ijgc-2019-esgo.100

Authors: S. Allan, F. Braiteh, E. Calvo Aller, A. Cervantes, W. Edenfield, T. Li, M. Rasschaert, T.W. Park-Simon, F. Longo, L. Paz-Ares, A. Spira, J. Strauss, L.S. Ojalvo, C. Helwig, I. Dussault, J.L. Gulley

Institutions: Comprehensive Cancer Centers of Nevada, Universitat de València, Prisma Health, UC Davis Comprehensive Cancer Center, Antwerp University Hospital, Medizinische Hochschule Hannover, Instituto Ramón y Cajal de Investigación Sanitaria, Centro de Investigación Biomédica en Red de Cáncer, Hospital Universitario Ramón y Cajal, Hospital Universitario 12 De Octubre, Virginia Cancer Specialists, The US Oncology Network, National Institutes of Health, National Cancer Institute, Center for Cancer Research, EMD Serono, Inc. (United States), Merck Healthcare KGaA, Darmstadt (Germany)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3006926063

Cites:

Cited by: 4

Related to: 10